Floatz logo

HUMAN FAECAL MATTER

Myeloma

University Hospital, Clermont-Ferrandother_biologicalPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

16 Active assets in the Myeloma cohort.

Asset / SponsorPhaseRating
SULFAMETHOXAZOLE
Monash University
Phase 3BB
Trimethoprim
Monash University
Phase 3BB
HUMAN IMMUNOGLOBULINS
Monash University
Phase 2/3BB
Lipitor
Fred Hutchinson Cancer Center
Phase 2BB
Campath
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase 2B

View all 43 →

Same molecule, other indications

HUMAN FAECAL MATTER is also rated in:

cirrhosis of liverDormant
BB
Indicative ·
66 / 100
View asset →
hepatic encephalopathyDormant
B
Indicative ·
61 / 100
View asset →
metabolic dysfunction-associated steatohepatitisDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →